STXBP1 and Cognitive impairment: We generated and validated mouse models of Stxbp1 haploinsufficiency specific to glutamatergic or GABAergic/glycinergic neurons and systematically determined their phenotypes in the three core disease domains—cognitive impairment, epilepsy, and motor dysfunction—as well as psychiatric functions and general health.